Guggenheim Capital LLC reduced its stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 66.7% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 33,728 shares of the real estate investment trust's stock after selling 67,424 shares during the period. Guggenheim Capital LLC's holdings in Omega Healthcare Investors were worth $1,277,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Johnson Investment Counsel Inc. grew its stake in shares of Omega Healthcare Investors by 2.3% in the 4th quarter. Johnson Investment Counsel Inc. now owns 13,147 shares of the real estate investment trust's stock valued at $498,000 after buying an additional 295 shares during the period. Bessemer Group Inc. lifted its holdings in Omega Healthcare Investors by 5.9% in the fourth quarter. Bessemer Group Inc. now owns 5,443 shares of the real estate investment trust's stock valued at $207,000 after acquiring an additional 303 shares during the last quarter. US Bancorp DE grew its position in Omega Healthcare Investors by 1.9% in the fourth quarter. US Bancorp DE now owns 16,173 shares of the real estate investment trust's stock worth $612,000 after acquiring an additional 309 shares during the period. Samalin Investment Counsel LLC grew its position in Omega Healthcare Investors by 1.5% in the fourth quarter. Samalin Investment Counsel LLC now owns 21,582 shares of the real estate investment trust's stock worth $817,000 after acquiring an additional 314 shares during the period. Finally, Loomis Sayles & Co. L P increased its stake in Omega Healthcare Investors by 27.6% during the fourth quarter. Loomis Sayles & Co. L P now owns 1,475 shares of the real estate investment trust's stock worth $56,000 after acquiring an additional 319 shares during the last quarter. 65.25% of the stock is owned by institutional investors and hedge funds.
Omega Healthcare Investors Stock Performance
NYSE OHI traded down $0.10 during trading hours on Friday, hitting $37.75. The company had a trading volume of 2,215,562 shares, compared to its average volume of 1,864,572. The business has a 50 day moving average of $37.38 and a 200-day moving average of $38.44. The company has a debt-to-equity ratio of 1.02, a quick ratio of 7.07 and a current ratio of 7.07. Omega Healthcare Investors, Inc. has a 1-year low of $30.26 and a 1-year high of $44.42. The company has a market cap of $10.84 billion, a PE ratio of 24.35, a price-to-earnings-growth ratio of 1.09 and a beta of 0.75.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its earnings results on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.41 by $0.33. Omega Healthcare Investors had a return on equity of 9.71% and a net margin of 38.65%. As a group, equities research analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.
Omega Healthcare Investors Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Monday, May 5th will be issued a $0.67 dividend. The ex-dividend date is Monday, May 5th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 7.10%. Omega Healthcare Investors's payout ratio is 172.90%.
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on the company. Truist Financial upped their price target on Omega Healthcare Investors from $38.00 to $39.00 and gave the company a "hold" rating in a research note on Tuesday, March 18th. Wells Fargo & Company cut shares of Omega Healthcare Investors from an "overweight" rating to an "equal weight" rating and decreased their target price for the company from $41.00 to $39.00 in a research report on Thursday, March 27th. Finally, JMP Securities reiterated a "market perform" rating on shares of Omega Healthcare Investors in a research report on Friday, February 7th. Six research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $42.00.
Check Out Our Latest Analysis on Omega Healthcare Investors
Omega Healthcare Investors Company Profile
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Further Reading
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
